These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 34812573)

  • 1. High serum fibroblast growth factor 21 is associated with inferior hepatocellular carcinoma survival: A prospective cohort study.
    Liu ZY; Luo Y; Fang AP; Wusiman M; He TT; Liu XZ; Yishake D; Chen S; Lu XT; Zhang YJ; Zhu HL
    Liver Int; 2022 Mar; 42(3):663-673. PubMed ID: 34812573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum folate concentrations at diagnosis are associated with hepatocellular carcinoma survival in the Guangdong Liver Cancer Cohort study.
    Fang AP; Liu ZY; Liao GC; Chen PY; Wang XY; Zhang DM; Luo Y; Long JA; Zhong RH; Zhou ZG; Xu YJ; Xu XJ; Ling WH; Chen MS; Zhang YJ; Zhu HL
    Br J Nutr; 2019 Jun; 121(12):1376-1388. PubMed ID: 30935429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum copper and zinc levels at diagnosis and hepatocellular carcinoma survival in the Guangdong Liver Cancer Cohort.
    Fang AP; Chen PY; Wang XY; Liu ZY; Zhang DM; Luo Y; Liao GC; Long JA; Zhong RH; Zhou ZG; Xu YJ; Xu XJ; Ling WH; Chen MS; Zhang YJ; Zhu HL
    Int J Cancer; 2019 Jun; 144(11):2823-2832. PubMed ID: 30426509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum Bioavailable, Rather Than Total, 25-hydroxyvitamin D Levels Are Associated With Hepatocellular Carcinoma Survival.
    Fang AP; Long JA; Zhang YJ; Liu ZY; Li QJ; Zhang DM; Luo Y; Zhong RH; Zhou ZG; Xu YJ; Xu XJ; Ling WH; Chen MS; Zhu HL
    Hepatology; 2020 Jul; 72(1):169-182. PubMed ID: 31677282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum S-adenosylhomocysteine, rather than homocysteine, is associated with hepatocellular carcinoma survival: a prospective cohort study.
    Wusiman M; Huang SY; Liu ZY; He TT; Fang AP; Li MC; Yang MT; Wang C; Zhang YJ; Zhu HL
    Am J Clin Nutr; 2024 Sep; 120(3):481-490. PubMed ID: 39025328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum choline is associated with hepatocellular carcinoma survival: a prospective cohort study.
    Liu ZY; Yishake D; Fang AP; Zhang DM; Liao GC; Tan XY; Zhang YJ; Zhu HL
    Nutr Metab (Lond); 2020; 17():25. PubMed ID: 32256673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dietary protein and prognosis of hepatocellular carcinoma: a prospective cohort study.
    Yishake D; He TT; Liu ZY; Chen S; Luo Y; Liu XZ; Huang RZ; Lan QY; Fang AP; Zhu HL
    Food Funct; 2021 Nov; 12(22):11568-11576. PubMed ID: 34709274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diverse Changes of Circulating Fibroblast Growth Factor 21 Levels in Hepatitis B Virus-Related Diseases.
    Wu L; Pan Q; Wu G; Qian L; Zhang J; Zhang L; Fang Q; Zang G; Wang Y; Lau G; Li H; Jia W
    Sci Rep; 2017 Nov; 7(1):16482. PubMed ID: 29184085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survival improvement and prognosis for hepatocellular carcinoma: analysis of the SEER database.
    Ding J; Wen Z
    BMC Cancer; 2021 Oct; 21(1):1157. PubMed ID: 34715816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dietary intake of one-carbon metabolism-related nutrients and hepatocellular carcinoma survival in the Guangdong Liver Cancer Cohort.
    He TT; Xiao HW; Wusiman M; Yishake D; Fang AP; Luo Y; Liu XZ; Liu ZY; Zhu HL
    Food Funct; 2022 Aug; 13(15):8081-8090. PubMed ID: 35792143
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liraglutide Decreases Liver Fat Content and Serum Fibroblast Growth Factor 21 Levels in Newly Diagnosed Overweight Patients with Type 2 Diabetes and Nonalcoholic Fatty Liver Disease.
    Li X; Wu X; Jia Y; Fu J; Zhang L; Jiang T; Liu J; Wang G
    J Diabetes Res; 2021; 2021():3715026. PubMed ID: 34660809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insight to the association among fibroblast growth factor 21, non-alcoholic fatty liver disease and cardiovascular outcomes: A population-based study.
    Shen Y; Hu T; Tan H; Xu Y; Wang Y; Ma X; Bao Y
    Cytokine; 2023 Oct; 170():156318. PubMed ID: 37549489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FIB-4 index serves as a noninvasive prognostic biomarker in patients with hepatocellular carcinoma: A meta-analysis.
    Zhang Y; Wang R; Yang X
    Medicine (Baltimore); 2018 Dec; 97(51):e13696. PubMed ID: 30572498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Prognostic Significance of NEK2 in Hepatocellular Carcinoma: Evidence from a Meta-Analysis and Retrospective Cohort Study.
    Cheng Y; Chen X; Ye L; Zhang Y; Liang J; Liu W; Zhou B; Zheng S; Huang Y; Chen G; Deng Y; Zhang Q; Yang Y
    Cell Physiol Biochem; 2018; 51(6):2746-2759. PubMed ID: 30562736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diabetes, metabolic comorbidities, and risk of hepatocellular carcinoma: Results from two prospective cohort studies.
    Simon TG; King LY; Chong DQ; Nguyen LH; Ma Y; VoPham T; Giovannucci EL; Fuchs CS; Meyerhardt JA; Corey KE; Khalili H; Chung RT; Zhang X; Chan AT
    Hepatology; 2018 May; 67(5):1797-1806. PubMed ID: 29152763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stratified neutrophil-to-lymphocyte ratio accurately predict mortality risk in hepatocellular carcinoma patients following curative liver resection.
    Huang GQ; Zhu GQ; Liu YL; Wang LR; Braddock M; Zheng MH; Zhou MT
    Oncotarget; 2016 Feb; 7(5):5429-39. PubMed ID: 26716411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk Factors for Hepatocellular Carcinoma Recurrence and Survival after Liver Transplantation in Patients with HCV-Related Cirrhosis.
    Vidal RIO; Vidal EIO; Pereira BB; Assane CC; Ribeiro A; do Nascimento EM; Romeiro FG; Ribeiro Filho J
    Biomed Res Int; 2020; 2020():1487593. PubMed ID: 33134370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The risk factors for long-term survival outcome in solitary hepatocellular carcinoma up to 2 cm: Propensity score matching analysis in a population cohort with a high rate of HBV infection.
    Wang G; Zhang W; Tan Y; Jiang L; Yang J; Yang J; Yan L
    Int J Surg; 2019 Dec; 72():1-6. PubMed ID: 31610283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between dietary patterns and prognosis of hepatocellular carcinoma in the Guangdong liver cancer cohort study.
    Luo Y; Zhang YJ; Zhang DM; Yishake D; Liu ZY; Chen MS; Wang F; Zhou ZG; Long JA; Zhong RH; Chen S; Lu XT; Li SY; He TT; Luo Y; Fang AP; Zhu HL
    Hepatol Res; 2020 Oct; 50(10):1164-1175. PubMed ID: 32691459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation of insulin-like growth factor-1 as a prognostic parameter in patients with hepatocellular carcinoma in a European cohort.
    Huber Y; Bierling F; Labenz C; Koch S; Schmidtmann I; Kloeckner R; Schotten S; Huber T; Lang H; Woerns MA; Galle PR; Weinmann A; Weinmann-Menke J
    BMC Cancer; 2018 Jul; 18(1):774. PubMed ID: 30064393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.